NCT02277743 Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT02274740 Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients Status TERMINATED Phase PHASE2
NCT02273258 A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT02273180 Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine Status COMPLETED Phase PHASE3
NCT02269098 The Synergy to Control Emergency Department Hyperglycemia Program for Type 2 Diabetes Status COMPLETED Phase NA
NCT02260986 Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT02254785 Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer Status UNKNOWN Phase PHASE2
NCT02227212 Ease of Use and Safety of the New U300 Pen Injector in Insulin-Naïve Patients With T2DM Status COMPLETED Phase PHASE3
NCT02218606 Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT02210780 Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD) Status COMPLETED Phase PHASE2
NCT02202772 Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02201199 Single Dose Clamp Study To Compare Concentration/Time Profile And Metabolic Activity Profile Of 2 New Formulations Of Insulin Glargine With Lantus Status COMPLETED Phase PHASE1
NCT02200991 Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine Status COMPLETED Phase PHASE4
NCT02193191 Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT02187848 Evaluation of SAR408701 in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT02181101 Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial Status COMPLETED Phase PHASE3
NCT02179970 To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers Status COMPLETED Phase PHASE1